After dramatic rebuke, AstraZeneca lowers vaccine efficacy estimate—a little – Ars Technica
Business News
- After dramatic rebuke, AstraZeneca lowers vaccine efficacy estimate—a little Ars Technica
- New AstraZeneca report says vaccine was 76% effective in preventing Covid-19 symptoms CNN
- AstraZeneca revises Covid vaccine data with lower efficacy rate after accuracy questions CNBC
- Covid Vaccine: Why Is AstraZeneca Making So Many Unforced Errors? Bloomberg
- Coronavirus: Vaccine diplomacy battle between major powers – opinion The Jerusalem Post
- View Full Coverage on Google News
Source: Business News